Costing Taxpayers Billions. Terminally ill patients left Medicare Advantage for traditional Medicare at double the rate o ...

We recently published a list of 11 Best Performing Large Cap Stocks So Far in 2025. In this article, we are going to take a ...

An unexpected disclosure rocked the health insurance world last week: CVS Health decided it was pulling out of the Affordable ...

The legislation would ensure Medicare beneficiaries have access to care and services provided by pharmacists within state ...

Gilead to Pay $202 Million to Settle DOJ Claims Over Speaker Program Kickbacks - Gilead Sciences, Inc. has agreed to pay $202 ...

Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced the Company has secured multiple market access ...

Biocon Biologics secures market access agreements for Yesintek, a biosimilar to Stelara, for treating autoimmune diseases in ...

The drug has been chosen as the sole ustekinumab by BCBSM, Florida Healthcare Plan, and other closed-door health systems.

YESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.

Pharmacy chain Rite Aid announced it began Chapter 11 proceedings Monday. Stores will remain open and the company will ...